1887
Research Open Access
Like 0

Abstract

Introduction

Viral hepatitis remains a significant threat to transfusion safety, although largely mitigated by donor screening.

Aim

Our objective was to estimate the past and present burden of transfusion transmission of all types of viral hepatitis (A to E) and to find undiagnosed infections with hepatitis C virus (HCV).

Method

We performed a retrospective cohort study using a database of the entire computerised transfusion experience of Sweden from 1968 to 2012 and linking it to a nationwide database of notifiable infections. We then used two independent statistical approaches. Firstly, we tracked recipients of blood from donors with confirmed viral hepatitis. Secondly, we computed a donor-specific risk score, defined as the difference between the observed and the expected number of HCV infections among all previous recipients of all donors, where thresholds were determined using simulation.

Results

Among 1,146,307 transfused patients, more than 5,000 were infected with HCV. Transfusion transmission only occurred before 1992 when donor screening had been completely implemented. Overall, we found 44 donors and 1,180 recipients likely to be infected with HCV who were still alive but who remained undiagnosed.

Conclusion

There is still a substantial number of individuals in Sweden who have probably been infected with HCV through blood transfusion and who are still unaware of their infection. We recommend that a follow-up study should be conducted to validate the method we used by approaching these individuals and offer testing. This would also serve as an opportunity to offer treatment to those who remain infected.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.29.1900537
2020-07-23
2020-10-28
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2020.25.29.1900537
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/29/eurosurv-25-29-2.html?itemId=/content/10.2807/1560-7917.ES.2020.25.29.1900537&mimeType=html&fmt=ahah

References

  1. Folkhälsomyndigheten (FHM). Smittsamma sjukdomar A-Ö. [Infectious diseases A–Z]. Stockholm: FHM. [Accessed 20 Jul 2020]. Swedish. Available from: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/smittsamma-sjukdomar/
  2. Folkhälsomyndigheten (FHM). Skattning av antalet personer som levermed en hepatit C-infektion i Sverige 2015. [Estimation of the number of individuals living with an HCV infection in Sweden 2015.[ Stockholm: FHM; 2016. ISBN 978-91-7603-688-4. Swedish. Available from: https://www.folkhalsomyndigheten.se/contentassets/2c53ba20ad2b40778a54485dedac7298/skattning-antalet-personer-lever-sverige-hepatit-c-infektion-16062-webb.pdf
  3. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood. 2008;112(7):2617-26.  https://doi.org/10.1182/blood-2008-07-077370  PMID: 18809775 
  4. Bowker SL, Smith LJ, Rosychuk RJ, Preiksaitis JK. A review of general hepatitis C virus lookbacks in Canada. Vox Sang. 2004;86(1):21-7.  https://doi.org/10.1111/j.0042-9007.2004.00380.x  PMID: 14984556 
  5. Culver DH, Alter MJ, Mullan RJ, Margolis HS. Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results. Transfusion. 2000;40(10):1176-81.  https://doi.org/10.1046/j.1537-2995.2000.40101176.x  PMID: 11061852 
  6. Soldan K, Ramsay M, Robinson A, Harris H, Anderson N, Caffrey E, et al. The contribution of transfusion to HCV infection in England. Epidemiol Infect. 2002;129(3):587-91.  https://doi.org/10.1017/S0950268802007744  PMID: 12558342 
  7. Davidson T, Ekermo B, Gaines H, Lesko B, Åkerlind B. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden. Transfusion. 2011;51(2):421-9.  https://doi.org/10.1111/j.1537-2995.2010.02877.x  PMID: 20849409 
  8. Edgren G, Hjalgrim H, Rostgaard K, Lambert P, Wikman A, Norda R, et al. Transmission of neurodegenerative disorders through blood transfusion: a cohort study. Ann Intern Med. 2016;165(5):316-24.  https://doi.org/10.7326/M15-2421  PMID: 27368068 
  9. Edgren G, Hjalgrim H, Rostgaard K, Dahl V, Titlestad K, Erikstrup C, et al. Searching for unknown transfusion-transmitted hepatitis viruses: a binational cohort study of 1.5 million transfused patients. J Intern Med. 2018;284(1):92-103.  https://doi.org/10.1111/joim.12762  PMID: 29624755 
  10. Edgren G, Hjalgrim H, Tran TN, Rostgaard K, Shanwell A, Titlestad K, et al. A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang. 2006;91(4):316-23.  https://doi.org/10.1111/j.1423-0410.2006.00827.x  PMID: 17105607 
  11. Edgren G, Rostgaard K, Vasan SK, Wikman A, Norda R, Pedersen OB, et al. The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility. Transfusion. 2015;55(7):1600-6.  https://doi.org/10.1111/trf.12986  PMID: 25573303 
  12. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659-67.  https://doi.org/10.1007/s10654-009-9350-y  PMID: 19504049 
  13. Rolfhamre P, Jansson A, Arneborn M, Ekdahl K. SmiNet-2: Description of an internet-based surveillance system for communicable diseases in Sweden. Euro Surveill. 2006;11(5):626.  https://doi.org/10.2807/esm.11.05.00626-en 
  14. Jansson A, Arneborn M, Ekdahl K. Sensitivity of the Swedish statutory surveillance system for communicable diseases 1998-2002, assessed by the capture-recapture method. Epidemiol Infect. 2005;133(3):401-7.  https://doi.org/10.1017/S0950268804003632  PMID: 15962546 
  15. Barbara JA, Howell DR, Briggs M, Parry JV. Post-transfusion hepatitis A. Lancet. 1982;1(8274):738.  https://doi.org/10.1016/S0140-6736(82)92644-7  PMID: 6122027 
  16. Diwan AH, Stubbs JR, Carnahan GE. Transmission of hepatitis A via WBC-reduced RBCs and FFP from a single donation. Transfusion. 2003;43(4):536-40.  https://doi.org/10.1046/j.1537-2995.2003.00342.x  PMID: 12662288 
  17. Gowland P, Fontana S, Niederhauser C, Taleghani BM. Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus. Transfusion. 2004;44(11):1555-61.  https://doi.org/10.1111/j.1537-2995.2004.04071.x  PMID: 15504159 
  18. Noble RC, Kane MA, Reeves SA, Roeckel I. Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA. 1984;252(19):2711-5.  https://doi.org/10.1001/jama.1984.03350190013011  PMID: 6492349 
  19. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, et al. Transfusion-transmitted hepatitis E in a ‘nonhyperendemic’ country. Transfus Med. 2006;16(2):79-83.  https://doi.org/10.1111/j.1365-3148.2006.00652.x  PMID: 16623913 
  20. Domanović D, Tedder R, Blümel J, Zaaijer H, Gallian P, Niederhauser C, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017;22(16):30514.  https://doi.org/10.2807/1560-7917.ES.2017.22.16.30514  PMID: 28449730 
  21. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384(9956):1766-73.  https://doi.org/10.1016/S0140-6736(14)61034-5  PMID: 25078306 
  22. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004;19(7):778-84.  https://doi.org/10.1111/j.1440-1746.2004.03437.x  PMID: 15209625 
  23. Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, Kato T, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004;44(6):934-40.  https://doi.org/10.1111/j.1537-2995.2004.03300.x  PMID: 15157263 
  24. Baylis SA, Gärtner T, Nick S, Ovemyr J, Blümel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 2012;103(1):89-90.  https://doi.org/10.1111/j.1423-0410.2011.01583.x  PMID: 22220775 
  25. Norda R, Duberg AS, Sönnerborg A, Olcén P. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992. Scand J Infect Dis. 1995;27(5):449-52.  https://doi.org/10.3109/00365549509047044  PMID: 8588133 
  26. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors--the role of parenteral and sexual transmission. Scand J Infect Dis. 1995;27(2):99-104.  https://doi.org/10.3109/00365549509018987  PMID: 7544914 
  27. Duberg AS, Hansdotter F, How AL, Holmström A, Lesko B. [Important with generous sampling for hepatitis C after blood transfusion. The National Board of Health and Welfare’s new recommendation for risk groups]. Lakartidningen. 2013;110(34-35):1477-9. PMID: 24044185 
  28. Ydreborg M, Söderström A, Håkanson A, Alsiö A, Arnholm B, Malmström P, et al. Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden. Scand J Infect Dis. 2011;43(6-7):522-7.  https://doi.org/10.3109/00365548.2011.562526  PMID: 21375426 
/content/10.2807/1560-7917.ES.2020.25.29.1900537
Loading

Data & Media loading...

Supplementary data

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error